Quantcast

Vaccine Offers Pig Farms Defense Against African Swine Fever Virus

FOOD SAFETY NEWS – A candidate vaccine, known as ASFV-G-DI177l—efficiently protects against African swine fever, USDA announced Thursday.

USDA’s Agricultural Research Service (ARS) published new research that highlights a new vaccine candidate that has been shown to prevent and effectively protect both European and Asia bred swine against the current circulating Asian strain of the virus.

A pandemic of African Swine Fever, centering on China, has swept through 14 Asian and European Counties since 2007, requiring those countries to destroy swine valued at $55 billion to $130 billion.

African Swine Fever has not reached North America, but it’s getting closer. AFS arrived this year on the Caribbean island of Hispaniola, shared by Haiti and the Dominican Republic.

The AFS virus is not a threat to human health and it is not transmitted from pigs to humans, nor does it put food safety at risk.

...article continued below
- Advertisement -

However, when it burns through entire swine populations, it has not been possible to stop it from destroying all the infected animals. That’s because until now there’s been no cure or vaccine.

Thursday’s report of a candidate vaccine being effective means North American pork producers may have a defense against the deadly virus before it reaches their pigs.

The USDA’s ARS reports that the vaccine candidate is effective in all swine by the fourth week after vaccination. It says “scientists have developed a vaccine candidate with the ability to be commercially produced while still maintaining the vaccine efficacy against Asian ASF virus strains when tested in both European and Asian swine breeds.”

“We are excited that our team’s research has resulted in forming vaccine candidates that are able to prevent and protect different swine breeds against the current ASF virus,” said ARS Administrator Chavonda Jacobs-Young. “Vaccine candidates could play an important role in controlling the outbreak threatening global swine health.”

Secretary of Agriculture Tom Vilsack applauded both ARS and USDA’s Animal and Plant Health Inspection Service (APHIS) for the progress on keeping AFS at bay.

...article continued below
- Advertisement -

“USDA agencies are working together to protect U.S. livestock from foreign and emerging diseases that could harm our economy and public health,” Vilsack said. “I am proud of the extraordinary research underway at the Agriculture Research Service to develop vaccine candidates to prevent African Swine Fever virus.”

The Secretary said APHIS has done “tremendous work” in protecting the U.S. swine industry. “Scientific research, discovery, surveillance, and detection are critical to solving challenging problems that American producers face keeping the food supply robust and safe,” he said.

The vaccine research, published in the journal Transboundary and Emerging Diseases, shows that ARS scientists have developed a vaccine candidate with the ability to be commercially produced while still maintaining its vaccine efficacy against Asian ASF virus strains when tested in both European and Asian swine breeds.

“This is a major step for science and agriculture,” said ARS researcher Manuel Borca. “We are working carefully to see our vaccine candidate commercialized through the joint efforts of the U.S. government, and our commercial partner, the Navetco National Veterinary Joint Stock Company.”

To date, ARS has successfully engineered and patented five ASF experimental vaccines and has fully executed seven licenses with pharmaceutical companies to develop the vaccines. ARS continues to evaluate additional commercial partners to develop these vaccines.

(To sign up for a free subscription to Food Safety News, click here.)

- Advertisement -

TRENDING

US Food Industry Poisons Consumers: Consumer Advocate

FOOD SAFETY NEWS – Some, I am sure, are a bit tired of my ranting about the FSIS doing its job and deeming Salmonella...

Judge Halts Federal Vaccine Mandate For Health Workers In Ten States

NEW HAMPSHIRE UNION-LEADER – A federal judge blocked the government on Monday from mandating COVID-19 vaccinations for health care workers in New Hampshire and...

Deadly Flu Season Forecast For Older Americans

WTOP – The flu season is beginning to gain traction with a predominant strain that concerns one infectious disease expert, and he’s urging everyone 6...

‘Vaccine Inequity’ Seen As Omicron Incubator

The emergence of the new omicron variant and the world's desperate and likely futile attempts to keep it at bay are reminders of what scientists have warned for months: The coronavirus will thrive as long as vast parts of the world lack vaccines.

Couple Pulled Off Plane After Fleeing Quarantine

Dutch authorities have isolated 61 people who tested positive for COVID-19 on two arriving flights originating from South Africa, Saturday, Nov. 27, 2021. Authorities are carrying out further investigations to see if any of the travelers have the omicron variant.

‘All-Or-Nothing’ Abortion Case Reaches Supreme Court

Both sides are telling the Supreme Court there’s no middle ground in Wednesday’s showdown over abortion. The justices can either reaffirm the constitutional right to an abortion or wipe it away altogether.

Omicron Finger-Pointing Begins

Many of the world's richest countries have spent the past year hoarding coronavirus vaccines, buying up enough doses to vaccinate their populations several times over and consistently failing to deliver on their promises to share doses with the developing world. The World Health Organization said the approach was "self-defeating" and "immoral."

Governors Urge Caution On Omicron

Governors across the United States tried to reassure Americans on Sunday that their administrations were closely monitoring the impact of a new coronavirus variant that has alarmed scientists.

FDA: Merck COVID Pill Effective, Safety Questions Remain

Federal health regulators say an experimental COVID-19 pill from Merck is effective against the virus, but they will seek input from outside experts on risks of birth defects and other potential problems during pregnancy.

Ivermectin, ‘Miracle Drug’?

MedPage Today – Pierre Kory, MD, one of the most vocal proponents of ivermectin, got COVID-19 in August, despite taking the anti-parasitic medication on...
- Advertisement -